Yücel Murat, Uğuz Emrah, Sağlam Muhammet Fethi, Erdoğan Kemal Eşref, Hıdıroğlu Mete, Alili Altay, Küçüker Şeref Alp
Department of Cardiovascular Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Department of Cardiovascular Surgery, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.
Diagnostics (Basel). 2025 Jun 11;15(12):1488. doi: 10.3390/diagnostics15121488.
This study aimed to evaluate the prognostic utility of systemic inflammatory markers, such as the Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), Monocyte-Lymphocyte Ratio (MLR), and Platelet-Lymphocyte Ratio (PLR), to identify patients at risk of developing surgically treated postpericardiotomy syndrome (PPS). A total of 150 patients were retrospectively analyzed. In total, 75 patients who developed postpericardiotomy syndrome requiring surgical drainage constituted the postpericardiotomy group, whereas 75 age- and surgically matched non-PPS patients served as the control group. Blood samples were collected at four time points: preoperative (T1), 24 h postoperative (T2), 7 days postoperative (T3), and 24 h before secondary intervention in the PPS group and the closest matched outpatient follow-up (T4) in the control group. Inflammatory marker values were compared within and between the groups at the four defined time points. Logistic regression and receiver operating characteristic (ROC) analyses were used to determine the diagnostic and predictive accuracy of each marker. Significant increases in the SIRI, MLR, and CRP levels were observed in patients who developed PPS and required surgical intervention. MLR on postoperative day 7 had the highest sensitivity (84%) with a cut-off of 0.575, whereas SIRI demonstrated the highest specificity (81.3%) at a cut-off of 3.34. SII increased significantly only in the late stage, indicating disease progression. The NLR lacked predictive power across all time points. The SIRI and MLR are promising early-stage biomarkers for identifying patients at high risk of developing PPS. Their integration into routine postoperative follow-up could facilitate earlier diagnosis and reduce surgical burden. A multi-marker approach may enhance the diagnostic precision of PPS beyond that of traditional inflammatory measures.
本研究旨在评估全身炎症标志物的预后效用,如全身免疫炎症指数(SII)、全身炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和血小板与淋巴细胞比值(PLR),以识别接受手术治疗的心包切开术后综合征(PPS)风险患者。共对150例患者进行了回顾性分析。总共有75例发生心包切开术后综合征需要手术引流的患者构成心包切开术后组,而75例年龄和手术情况匹配的非PPS患者作为对照组。在四个时间点采集血样:术前(T1)、术后24小时(T2)、术后7天(T3),以及PPS组二次干预前24小时和对照组最接近的门诊随访时间(T4)。在四个定义的时间点对组内和组间的炎症标志物值进行比较。采用逻辑回归和受试者工作特征(ROC)分析来确定每个标志物的诊断和预测准确性。发生PPS并需要手术干预的患者中,观察到SIRI、MLR和CRP水平显著升高。术后第7天的MLR敏感性最高(84%),截断值为0.575,而SIRI在截断值为3.34时特异性最高(81.3%)。SII仅在晚期显著升高,表明疾病进展。NLR在所有时间点均缺乏预测能力。SIRI和MLR是用于识别发生PPS高风险患者的有前景的早期生物标志物。将它们纳入术后常规随访可促进早期诊断并减轻手术负担。多标志物方法可能比传统炎症指标提高PPS的诊断精度。